HorizonMedical™’s Daylily® Embryo Transfer Catheter Gets FDA Approval

Shanghai, China, 10 January 2023 - The Daylily® Embryo Transfer Catheter, independently developed by HorizonMedical™, successfully received Food and Drug Administration (FDA) 510(k) approval, becoming the first HorizonMedical™ product to obtain approval in the United States of America (U.S.).

The Daylily® Embryo Transfer Catheter is used in embryo transfer procedures, allowing doctors to gently implant in vitro embryos into the uterine cavity via the cervix relatively quickly. The catheter’s design comprises a smooth tip, which can effectively reduce irritation to the uterus, and a highly flexible guide, which is easy to manipulate. The addition of a matching stylet offers an effective solution to anteflexion and retroflexion embryo transfer.

This product has passed stringent positive and negative pressure tests, ensuring little to no risk of fluid or air leakage during its use. Available in a variety of sizes, the Daylily® Embryo Transfer Catheter provides doctors with a wide selection to fit their usage habits and variable patient conditions.

Dr. Zong Guo, Executive Vice President of HorizonMedical™ has stated: “The Daylily® Embryo Transfer Catheter was registered and approved in China in 2020 and in Thailand in 2021, and has received recognition by experts in clinical applications. The FDA 510(K) marketing approval is a milestone for HorizonMedical™ to grow in the U.S. market. In the future, Horizon Medical™ will further improve its product portfolio and accelerate its market expansion both domestically and globally.”

About HorizonMedical™

As a subsidiary of MicroPort® and focusing on medical solutions in the field of assisted reproduction, Shanghai Horizon Medical Co., Ltd. (HorizonMedical™) develops, manufactures, sells and provides technical support for medical products used in all stages of an assisted reproductive cycle. This includes egg retrieval and fertilization, freezing and storage of gametes and embryos, cultivation and processing of gametes and embryos, as well as embryo implantation. HorizonMedical™ currently has other products approved for sale in China, including the Lotus® single-use sterile egg retrieval needles.